Swipe om te navigeren naar een ander artikel
Comparative assessment of the HRQL of paediatric survivors of brain tumours (BT) and of acute leukaemia against a population of their healthy peers.
The study consisted of patients who had completed treatment for BT (n = 36) or acute leukaemia (n = 35) and were aged between 8 and 19. Healthy children (n = 60) were selected from among pupils of schools. HRQL was evaluated directly and indirectly on the basis of the Polish language version of the PedsQL™ 4.0 Generic Core scales. The influence of selected factors (sex, age, time from the end of treatment and type of treatment) on the HRQL result was analysed.
In all the aspects analysed (total, physical, psychosocial, emotional, social and school functioning), the HRQL of BT and leukaemia survivors was significantly lower in comparison to their healthy peers. The HRQL of patients after BT treatment was also significantly lower than that of the survivors of leukaemia. The parent-proxy reported HRQL was consistent with the children’s self-assessment. Patients treated with radiotherapy presented a significantly lower evaluation of life quality in the physical sphere.
Evaluation of HRQL should be treated as an additional independent parameter in an assessment of the long-term results of oncological treatment.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Gurney, J. G., Smith, M. A., Bunin, G. R. (1999). CNS and miscellaneous intracranial and intraspinal neoplasms. In L. A. G. Ries, M. A. Smith, J. G. Gurney, et al. (Eds.), Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995 (pp. 51–64). Bethesda, MD: National Cancer Institute, SEER Program. NIH Pub. No. 99-4649.
Ries, L. A. G., Eisner, M. P., Kosary, C. L., Hankey, B. F., Miller, B. A., Clegg, L., et al. (2004). SEER cancer statistics review, 1975–2002. http://seer.cancer.gov/csr/1975_2002/. Posted to the SEER web site 2005.
Mertens, A. C., Yasui, Y., Neglia, J. P., Potter, J. D., Nesbit, M. E., Jr., Ruccione, K., et al. (2001). Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. Journal of Clinical Oncology, 19(13), 3163–3172. PubMed
Moller, T. R., Garwicz, S., Barlow, L., Falck Winther, J., Glattre, E., Olafsdottir, G., et al. (2001). Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: A population-based study in the Nordic countries. Journal of Clinical Oncology, 19(13), 3173–3181. PubMed
Eiser, C., Vance, Y. H., Horne, B., Glaser, A., & Galvin, H. (2003). The value of the PedsQLTM in assessing quality of life in survivors of childhood cancer. Child: Care, Health and Development, 29(2), 95–102. CrossRef
Cardarelli, C., Cereda, C., Masiero, L., Viscardi, E., Faggin, R., Laverda, A., et al. (2006). Evaluation of health status and health-related quality of life in a cohort of Italian children following treatment for a primary brain tumor. Pediatric Blood & Cancer, 46, 637–644. CrossRef
Foreman, N. K., Faestel, P. M., Pearson, J., Disabato, J., Poole, M., Wilkening, G., et al. (1999). Health status in 52 long-term survivors of pediatric brain tumors. Journal of Neurooncology, 41, 47–53. CrossRef
Meeske, K. A., Patel, S. K., Palmer, S. N., Nelson, M. B., & Parow, A. M. (2007). Factors associated with health-related quality of life in pediatric cancer survivors. Pediatric Blood & Cancer, 49, 298–305. CrossRef
Palmer, S. N., Meeske, K. A., Katz, E. R., Burwinkle, T. M., & Varni, J. W. (2007). The PedsQL brain tumor module: Initial reliability and validity. Pediatric Blood & Cancer, 49(3), 287–293. CrossRef
Szaflarski, M., & Cubbins, L. A. (2004). Self-reported health in Poland and the United States: A comparative analysis of demographic, family and socioeconomic influences. Health (London), 8(1), 5–31. CrossRef
Mulhern, R. K., & Butler R. W. (2004). Neurocognitive sequelae of childhood cancers and their treatment . Pediatric Rehabilitation, 7(1), 1–14 (discussion 15–16).
Luttjeboer, M., & Kaspers, G. J. (2006). Medulloblastoma: Need for targeted treatment. Expert Reviews of Anticancer Therapy, 6(5), 649–652. CrossRef
- Health-related quality of life among paediatric survivors of primary brain tumours and acute leukaemia
- Springer Netherlands